查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1409884

2024 年關節內粘稠補充療法全球市場報告

Viscosupplementation Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來關節內粘稠補充療法的市場規模迅速擴大。將從2023年的37.4億美元成長到2024年的41.5億美元，複合年成長率為11.0%。歷史時期觀察到的成長是由於多種因素造成的，包括人口老化、肥胖率增加、保險覆蓋範圍擴大、個人意識提高、患者偏好以及骨關節炎相關病例顯著增加。這是由於以下因素。這些因素共同促進了這段時期關節內粘稠補充療法的擴展和採用。

關節內粘稠補充療法市場的領先公司正在積極創新，以確保競爭優勢。一個著名的例子是 Nuvo Pharmaceuticals Inc.，這是一家加拿大製藥公司，於 2021 年 1 月在加拿大市場推出了 NeoVisc+2mL 和 NeoVisc ONE 4mL。這些產品是透明質酸 (HA) 黏液補充品，專為緩解膝關節退化性和機械性關節病變（通常與膝骨關節炎相關）患者的疼痛和增強關節功能而設計。 NeoVisc+2mL 和 NeoVisc ONE 4mL 的推出突顯了 Nuvo Pharmaceuticals Inc. 致力於為膝關節疼痛和膝骨關節炎提供尖端治療選擇，包括在加拿大關節內粘稠補充療法。我們正在為整體成長做出貢獻市場。

2023年，北美是關節內粘稠補充療法市場最大的地區。關節內粘稠補充療法市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章 關節關節內粘稠補充療法市場特點

第3章關節關節內粘稠補充療法市場趨勢與策略

第4章關節內粘稠補充療法市場－宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章全球關節內粘稠補充療法市場規模與成長

  • 市場促進因素/市場抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023 年市場規模與成長表現
  • 2023-2028、2033 年市場規模與成長預測

第6章關節內粘稠補充療法市場區隔

  • 全球關節內粘稠補充療法市場，按類型、實際和預測細分，2018-2023、2023-2028、2033
  • 單次注射
  • 3次注射
  • 5次注射
  • 全球關節內粘稠補充療法市場，依來源、表現及預測細分，2018-2023、2023-2028、2033
  • 鳥類
  • 非禽類的
  • 全球關節內粘稠補充療法市場，按透明質酸細分，表現和預測，2018-2023、2023-2028、2033
  • 標準玻尿酸
  • 穩定化透明質酸
  • 全球關節內粘稠補充療法市場，按應用、表現和預測細分，2018-2023、2023-2028、2033
  • 膝骨關節炎
  • 髖骨關節炎
  • 手腕手腕關節
  • 全球關節內粘稠補充療法市場，按最終用戶細分、績效和預測，2018-2023、2023-2028、2033
  • 醫院
  • 門診手術中心
  • 其他

第7章關節關節內粘稠補充療法市場區域與國家分析

  • 全球關節內粘稠補充療法市場，依地區、績效及預測，2018-2023、2023-2028、2033
  • 全球關節內粘稠補充療法市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太關節關節內粘稠補充療法市場

第9章 中國關節內粘稠補充療法市場

第10章 印度關節內粘稠補充療法市場

第11章：日本關節內粘稠補充療法市場

第12章 澳洲關節內粘稠補充療法市場

第13章印尼關節內粘稠補充療法市場

第14章 韓國關節內粘稠補充療法市場

第15章西歐關節內粘稠補充療法市場

第16章英國關節內粘稠補充療法市場

第17章 德國關節內粘稠補充療法市場

第18章 法國關節內粘稠補充療法市場

第19章 義大利關節內粘稠補充療法市場

第20章 西班牙關節內粘稠補充療法市場

第21章 東歐關節內粘稠補充療法市場

第22章俄羅斯關節內粘稠補充療法市場

第23章北美關節內粘稠補充療法市場

第24章美國關節內粘稠補充療法市場

第25章加拿大關節內粘稠補充療法市場

第26章南美關節內粘稠補充療法市場

第27章巴西關節內粘稠補充療法市場

第28章中東關節內粘稠補充療法市場

第29章非洲關節內粘稠補充療法市場

第30章 競爭形勢及公司概況

  • 關節內粘稠補充療法市場競爭形勢
  • 關節關節內粘稠補充療法市場公司概況
    • Seikagaku Corporation
    • Anika Therapeutics Inc.
    • Bioventus LLC
    • Sanofi SA
    • Zimmer Biomet

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章 重大併購

第34章 未來展望及可能性分析

第35章附錄

簡介目錄
Product Code: r11422

“Viscosupplementation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viscosupplementation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The viscosupplementation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
  • 2) By Source: Avian Origin; Non-Avian Origin
  • 3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
  • 4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus LLC; Sanofi S.A.; Zimmer Biomet
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Viscosupplementation involves the injection of hyaluronic acid gel directly into the joint to alleviate friction during movement. Hyaluronic acid, naturally present in synovial fluid surrounding joints, aids in reducing friction during joint motion.

The primary types of viscosupplementation include single-injection, three-injection, and five-injection methods. Single-injection viscosupplementation entails a direct injection of hyaluronic acid into the knee's diarthrodial joints, restoring the synovial fluid's rheological properties to generate anti-inflammatory and analgesic effects. Hyaluronic acid variations such as standard and stabilized forms, sourced from avian and non-avian origins, are used to address various osteoarthritic conditions such as knee, hip, and hand osteoarthritis. These treatments are administered across diverse healthcare settings, including hospitals, ambulatory surgical centers, among others.

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends, and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation market size has grown rapidly in recent years. It will grow from $3.74 billion in 2023 to $4.15 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historic period can be attributed to several factors, including an aging population, increasing rates of obesity, improved insurance coverage, heightened awareness among individuals, patient preferences, and a notable rise in cases related to osteoarthritis. These elements collectively contributed to the expansion and adoption of viscosupplementation treatments during this period.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $6.19 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The projected growth in the upcoming period can be linked to several factors such as continued regulatory backing, the emergence of alternative payment structures, amplified healthcare expenditure, ongoing research and development efforts, and the widening of treatment applications. Key trends anticipated during this period encompass outcome-centric payment frameworks, initiatives focused on educating patients, advancements in biomarker development, ongoing exploration of gene therapy, and the implementation of value-based care models. These trends are expected to shape and drive the expansion of viscosupplementation practices in healthcare.

The increasing prevalence of osteoarthritis is poised to be a significant driver for the viscosupplementation market in the foreseeable future. Osteoarthritis, a degenerative joint disease and a common form of arthritis, manifests in the breakdown of joints, particularly in areas such as the hips, knees, and hands. Viscosupplementation treatment, involving the direct injection of hyaluronic acid into bone joints, serves to alleviate pain and enhance smooth bone movement. According to the Centers for Disease Control and Prevention (CDC), an American public health service organization, a projected 78.4 million adults aged 18 years and older in the USA are expected to be afflicted by arthritis by the year 2040. This underscores the pivotal role of the rising prevalence of osteoarthritis in propelling the growth trajectory of the viscosupplementation market.

Anticipated growth in healthcare expenditure is set to foster the expansion of the viscosupplementation market in the coming years. Healthcare expenditure, denoting the total spending on healthcare costs, encompasses the financial outlay on healthcare-related goods and services within a specific healthcare system or economy. The surge in healthcare expenditure plays a pivotal role in advancing the broader adoption and increased accessibility of viscosupplementation. This support extends to various aspects, including research, training, infrastructure development, and coverage by healthcare plans, ultimately benefiting individuals grappling with joint-related issues. As of November 2022, the Canadian Institute for Health Information, a U.S.-based not-for-profit organization, reported a notable increase in healthcare expenditure to 0.8%, reaching $331 billion in 2022, compared to 7.6% in 2021. Consequently, the upward trajectory of healthcare expenditure emerges as a driving force behind the growth of the viscosupplementation market.

The viscosupplementation market is witnessing a surge in popularity driven by advancements in technology. Companies within this market are strategically embracing new technologies to maintain their competitive edge. In August 2021, Seikagaku Corporation, a prominent Japanese pharmaceutical firm, unveiled HyLink, an innovative viscosupplement designed for intra-articular single injection to address knee osteoarthritis. HyLink incorporates cross-linking technology, a method used to create a long-lasting cross-linked hyaluronate hydrogel that effectively persists in the joint cavity, establishing it as a durable treatment solution. This move reflects Seikagaku Corporation's commitment to staying at the forefront of technological developments within the viscosupplementation sector.

Leading companies in the viscosupplementation market are actively pursuing innovation to secure a competitive advantage. A notable example is Nuvo Pharmaceuticals Inc., a Canada-based pharmaceutical company, which, in January 2021, introduced NeoVisc+ 2 mL and NeoVisc ONE 4 mL in the Canadian market. These products are hyaluronic acid (HA) viscosupplements specifically designed to address pain relief and enhance joint functionality in patients with degenerative or mechanical arthropathy of the knee, commonly associated with osteoarthritis. The launch of NeoVisc+ 2 mL and NeoVisc ONE 4 mL underscores Nuvo Pharmaceuticals Inc.'s dedication to delivering cutting-edge treatment options for knee pain and osteoarthritis, contributing to the overall growth of the viscosupplementation market in Canada.

In December 2021, Avanos Medical Inc., a medical technology company based in the United States, successfully completed the acquisition of OrthogenRx Inc. for a total transaction value of $160 million. This strategic move significantly expanded, diversified, and enhanced Avanos Medical Inc.'s chronic pain product portfolio, specifically by incorporating treatment options for individuals with knee osteoarthritis. The acquisition was strategically aligned with the company's objective to fortify its partnerships with healthcare providers on a global scale, particularly in the realm of musculoskeletal pain treatment. OrthogenRx Inc., a U.S.-based medical device company with expertise in viscosupplementation therapies for knee osteoarthritis, played a pivotal role in reinforcing Avanos Medical Inc.'s position in this therapeutic space.

Major companies operating in the viscosupplementation market report are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Sanofi S.A., Zimmer Biomet, Avanos Medical Inc., Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Teva Pharmaceutical Industries Ltd., Merck KGaA, Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Wellchem Pharmaceuticals Pte Ltd., Chugai Pharmaceutical Corp., Laboratoires VIVACY, LG Life Sciences Ltd., Miravo Healthcare, Neopharmed Gentili S.p.A., SingHealth Group., Viatris, Allergan, Hoffmann-La Roche, Meda Pharmaceuticals, Merz Pharma, Mylan N.V., Novartis International AG .

North America was the largest region in the viscosupplementation market in 2023. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Viscosupplementation Market Characteristics

3. Viscosupplementation Market Trends And Strategies

4. Viscosupplementation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Viscosupplementation Market Size and Growth

  • 5.1. Global Viscosupplementation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Viscosupplementation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Viscosupplementation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Viscosupplementation Market Segmentation

  • 6.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation
  • 6.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Avian Origin
  • Non-Avian Origin
  • 6.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Standard Hyaluronic Acid
  • Stabilized Hyaluronic Acid
  • 6.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • 6.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

7. Viscosupplementation Market Regional And Country Analysis

  • 7.1. Global Viscosupplementation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Viscosupplementation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Viscosupplementation Market

  • 8.1. Asia-Pacific Viscosupplementation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Viscosupplementation Market

  • 9.1. China Viscosupplementation Market Overview
  • 9.2. China Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Viscosupplementation Market

  • 10.1. India Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Viscosupplementation Market

  • 11.1. Japan Viscosupplementation Market Overview
  • 11.2. Japan Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Viscosupplementation Market

  • 12.1. Australia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Viscosupplementation Market

  • 13.1. Indonesia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Viscosupplementation Market

  • 14.1. South Korea Viscosupplementation Market Overview
  • 14.2. South Korea Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Viscosupplementation Market

  • 15.1. Western Europe Viscosupplementation Market Overview
  • 15.2. Western Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Viscosupplementation Market

  • 16.1. UK Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Viscosupplementation Market

  • 17.1. Germany Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Viscosupplementation Market

  • 18.1. France Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Viscosupplementation Market

  • 19.1. Italy Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Viscosupplementation Market

  • 20.1. Spain Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Viscosupplementation Market

  • 21.1. Eastern Europe Viscosupplementation Market Overview
  • 21.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Viscosupplementation Market

  • 22.1. Russia Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Viscosupplementation Market

  • 23.1. North America Viscosupplementation Market Overview
  • 23.2. North America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Viscosupplementation Market

  • 24.1. USA Viscosupplementation Market Overview
  • 24.2. USA Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Viscosupplementation Market

  • 25.1. Canada Viscosupplementation Market Overview
  • 25.2. Canada Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Viscosupplementation Market

  • 26.1. South America Viscosupplementation Market Overview
  • 26.2. South America Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Viscosupplementation Market

  • 27.1. Brazil Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Viscosupplementation Market

  • 28.1. Middle East Viscosupplementation Market Overview
  • 28.2. Middle East Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Viscosupplementation Market

  • 29.1. Africa Viscosupplementation Market Overview
  • 29.2. Africa Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Viscosupplementation Market Competitive Landscape And Company Profiles

  • 30.1. Viscosupplementation Market Competitive Landscape
  • 30.2. Viscosupplementation Market Company Profiles
    • 30.2.1. Seikagaku Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Anika Therapeutics Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bioventus LLC
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Zimmer Biomet
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Viscosupplementation Market Competitive Benchmarking

32. Global Viscosupplementation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Viscosupplementation Market

34. Viscosupplementation Market Future Outlook and Potential Analysis

  • 34.1 Viscosupplementation Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Viscosupplementation Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Viscosupplementation Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer